Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip M Arlen

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|November 28, 2008
Therapeutic prostate cancer vaccines: a review of the latest developmentsMahsa Mohebtash, Ravi A Madan, James L Gulley, et al.
Expert Review of Vaccines|January 9, 2004
Strategies for the development of PSA-based vaccines for the treatment of advanced prostate cancerPhilip M Arlen, James L Gulley, Kwong-Yok Tsang, et al.
Current Opinion in Molecular Therapeutics|January 27, 2009
Cancer vaccines: current directions and perspectives in prostate cancerMahsa Mohebtash, James L Gulley, Ravi A Madan, et al.
American Journal of Therapeutics|March 16, 2005
Prolonged response to nilutamide in a patient with stage D0.5 prostate cancer who previously failed androgen deprivation therapyNushin F Todd, Ronald Lieberman, James L Gulley, et al.
American Journal of Therapeutics|May 23, 2007
Significant prostate-specific antigen (PSA) response to low-dose ketoconazole in a patient with non-metastatic androgen-independent prostate cancer (AIPC) and a review of the literatureRavi A Madan, Ron Lieberman, James L Gulley, et al.
Current Drug Delivery|January 31, 2012
The use of specific monoclonal antibodies to target immunogenic tumor membrane proteins in patients with recurrent pancreatic and colon cancerMyron Arlen, XuePing Wang, Janos Luka, et al.
Update on Cancer Therapeutics|October 20, 2007
Combining Vaccines with Conventional Therapies for CancerPhilip M Arlen, Ravi A Madan, James W Hodge, et al.
Critical Reviews in Immunology|January 17, 2008
Preclinical and clinical studies of recombinant poxvirus vaccines for carcinoma therapyPhilip M Arlen, James L Gulley, Ravi A Madan, et al.
Expert Opinion on Investigational Drugs|June 25, 2009
Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancerRavi A Madan, Philip M Arlen, Mahsa Mohebtash, et al.
Journal of Immunological Methods|September 13, 2003
A novel ELISPOT assay to enhance detection of antigen-specific T cells employing antigen-presenting cells expressing vector-driven human B7-1Philip M Arlen, James L Gulley, Claudia Palena, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Current Opinion in Investigational Drugs (London, England : 2000)|November 28, 2008
Therapeutic prostate cancer vaccines: a review of the latest developmentsMahsa Mohebtash, Ravi A Madan, James L Gulley, et al.
Expert Review of Vaccines|January 9, 2004
Strategies for the development of PSA-based vaccines for the treatment of advanced prostate cancerPhilip M Arlen, James L Gulley, Kwong-Yok Tsang, et al.
Current Opinion in Molecular Therapeutics|January 27, 2009
Cancer vaccines: current directions and perspectives in prostate cancerMahsa Mohebtash, James L Gulley, Ravi A Madan, et al.
American Journal of Therapeutics|March 16, 2005
Prolonged response to nilutamide in a patient with stage D0.5 prostate cancer who previously failed androgen deprivation therapyNushin F Todd, Ronald Lieberman, James L Gulley, et al.
American Journal of Therapeutics|May 23, 2007
Significant prostate-specific antigen (PSA) response to low-dose ketoconazole in a patient with non-metastatic androgen-independent prostate cancer (AIPC) and a review of the literatureRavi A Madan, Ron Lieberman, James L Gulley, et al.
Current Drug Delivery|January 31, 2012
The use of specific monoclonal antibodies to target immunogenic tumor membrane proteins in patients with recurrent pancreatic and colon cancerMyron Arlen, XuePing Wang, Janos Luka, et al.
Update on Cancer Therapeutics|October 20, 2007
Combining Vaccines with Conventional Therapies for CancerPhilip M Arlen, Ravi A Madan, James W Hodge, et al.
Critical Reviews in Immunology|January 17, 2008
Preclinical and clinical studies of recombinant poxvirus vaccines for carcinoma therapyPhilip M Arlen, James L Gulley, Ravi A Madan, et al.
Expert Opinion on Investigational Drugs|June 25, 2009
Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancerRavi A Madan, Philip M Arlen, Mahsa Mohebtash, et al.
Journal of Immunological Methods|September 13, 2003
A novel ELISPOT assay to enhance detection of antigen-specific T cells employing antigen-presenting cells expressing vector-driven human B7-1Philip M Arlen, James L Gulley, Claudia Palena, et al.
Pageof 9